Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Indivior (INDV) Share News

12345678910

TOP NEWS: Indivior pays USD385 million to end Suboxone antitrust case

23rd Oct 2023 08:40

(Alliance News) - Indivior PLC on Monday said it has reached an agreement to settle a US multi-district Suboxone litigation case, forking out USD385 million in the process. Read More

LONDON MARKET CLOSE: FTSE 100 tips into red as housebuilders struggle

21st Aug 2023 16:49

(Alliance News) - Stocks in London were lower at the close on Monday, with the FTSE 100 tipping into the red as its blue-chip housebuilders were hurt by less-than-stellar data from Rightmove and a profit warning from FTSE 250 peer Crest Nicholson. Read More

LONDON MARKET MIDDAY: Crest Nicholson warning hits housing shares

21st Aug 2023 12:04

(Alliance News) - Stock prices in London were mixed at midday Monday, after a profit warning from Crest Nicholson, as well as some poor data from Rightmove, rattled stocks in the housebuilding sector. Read More

Indivior to settle litigation with USD30 million payment to claimants

21st Aug 2023 08:27

(Alliance News) - Indivior PLC on Monday announced it is resolving claims brought in antitrust multi-district litigation regarding its drug Suboxone by paying claimants millions of dollars. Read More

TRADING UPDATES: C4X Discovery inks Indivior deal, Digitalbox expands

1st Aug 2023 17:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

LONDON BROKER RATINGS: KBW cuts Aviva 'market perform'

28th Jul 2023 09:46

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday: Read More

Indivior raises 2023 guidance after strong half-year progress

27th Jul 2023 11:48

(Alliance News) - Indivior PLC on Thursday celebrated a strong recent six months and second quarter that brough increased profit and revenue, boosting its optimism for the rest of the year. Read More

LONDON BRIEFING: Shares on the rise; Frasers buys into AO World

12th Jun 2023 07:53

(Alliance News) - Stocks in London were set to open higher on Monday, at the start of a busy week of central bank moves. Read More

Indivior settles antitrust claims in US regarding Suboxone drug

2nd Jun 2023 18:18

(Alliance News) - Indivior PLC on Friday said it has reached an agreement to resolve the claims brought in antitrust multi-district litigation regarding its drug Suboxone. Read More

LONDON BROKER RATINGS: Numis starts Tristel with 'add'

25th May 2023 09:23

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning: Read More

Indivior emergency opioid overdose treatment approved by US FDA

23rd May 2023 09:56

(Alliance News) - Indivior PLC on Tuesday said the US Food & Drug Administration has approved its OPVEE nasal spray for the emergency treatment of opioid overdose. Read More

DIRECTOR DEALINGS: Indivior division chief sells GBP1.7 million shares

10th May 2023 17:02

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

27th Apr 2023 15:49

Read More

Indivior raises 2023 revenue forecast following Opiant acquisition

27th Apr 2023 13:46

(Alliance News) - Indivior PLC on Thursday said net revenue increased by more than 20% in the first quarter, lifting profit, and it updated its guidance for the year following its acquisition of Opiant Pharmaceuticals Inc last month. Read More

UK earnings, trading statements calendar - next 7 days

20th Apr 2023 15:41

Read More

IN BRIEF: Indivior completes acquisition of Opiant Pharmaceuticals

2nd Mar 2023 17:47

Indivior PLC - North Chesterfield, Virginia-based pharmaceutical company - Completes the acquisition of Opiant Pharmaceuticals Inc. Says the acquisition will strengthen its addiction treatment and science portfolio through the addition of Opiant's late-stage assets, notably OPNT003, an investigational opioid overdose treatment. Read More

LONDON BROKER RATINGS: Berenberg lowers Spectris; RBC cuts Direct Line

20th Feb 2023 09:15

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday: Read More

LONDON MARKET CLOSE: Records for FTSE and CAC but US PPI hits New York

16th Feb 2023 16:55

(Alliance News) - Blue-chip benchmarks in London and Paris hit record highs on Thursday, with the FTSE 100 managing to cling to its daily gain, despite some weakness following US producer price data. Read More

CORRECT: LONDON MARKET MIDDAY: FTSE 100 stays above 8,000

16th Feb 2023 12:19

(Correcting the GBPUSD quote). Read More

LONDON MARKET MIDDAY: FTSE 100 stays above 8,000 as Centrica jumps

16th Feb 2023 12:07

(Alliance News) - Stock prices in London were higher at midday on Thursday, with London's flagship index still trading above the 8,000 mark on the back of strong performances from Centrica and Relx. Read More

12345678910
FTSE 100 Latest
Value8,275.66
Change0.00